Lactic acid bacteria with health claims -: interactions and interference with gastrointestinal flora

被引:96
作者
Mattila-Sandholm, T [1 ]
Mättä, J [1 ]
Saarela, M [1 ]
机构
[1] VTT Biotechnol & Food Res, Vtt 02044, Finland
关键词
probiotics; lactic acid bacteria; gastrointestinal flora; safety; antimicrobials; antibiotics;
D O I
10.1016/S0958-6946(99)00041-2
中图分类号
TS2 [食品工业];
学科分类号
0832 ;
摘要
Lactic acid bacteria in foods have a long history of safe use. Members of the genera Lactococcus and Lactobacillus have a 'generally-recognised-as-safe' status, whilst members of the genera Streptococcus and Enterococcus and some other genera of lactic acid bacteria contain opportunistic pathogens. New species and more specific strains of probiotic bacteria are constantly being identified. Prior to incorporating new strains into products their efficacy should be carefully assessed and a case-by-case evaluation of whether they share the safety status of traditional food-grade organisms should be made. Genetically modified organisms are by definition always novel. Any safety assessment is based on the decision of the novel status, including phenotypic and genotypic characterisation. Additionally, for genetically modified organisms and their products, information is required in the following categories: effects of the genetic modification on the properties of the host organism, genetic stability of the genetically modified organism, specificity of expression of novel genetic material, transfer of genetic material from genetically modified organisms, and the ability of genetically modified microorganisms to colonise and to survive in the human gut. (C) 1999 Elsevier Science Ltd. All rights reserved.
引用
收藏
页码:25 / 35
页数:11
相关论文
共 89 条
[71]   Lactobacilli and bacteremia in southern Finland, 1989-1992 [J].
Saxelin, M ;
Chuang, NB ;
Chassy, B ;
Rautelin, H ;
Makela, PH ;
Salminen, S ;
Gorbach, SL .
CLINICAL INFECTIOUS DISEASES, 1996, 22 (03) :564-566
[72]   Safety of commercial products with viable Lactobacillus strains [J].
Saxelin, M ;
Rautelin, H ;
Salminen, S ;
Makela, PH .
INFECTIOUS DISEASES IN CLINICAL PRACTICE, 1996, 5 (05) :331-335
[73]   IMMUNOMODULATION OF HUMAN BLOOD-CELLS FOLLOWING THE INGESTION OF LACTIC-ACID BACTERIA [J].
SCHIFFRIN, EJ ;
ROCHAT, F ;
LINKAMSTER, H ;
AESCHLIMANN, JM ;
DONNETHUGHES, A .
JOURNAL OF DAIRY SCIENCE, 1995, 78 (03) :491-497
[74]   EVIDENCE FOR NATURAL TRANSFER OF A TETRACYCLINE RESISTANCE GENE BETWEEN BACTERIA FROM THE HUMAN COLON AND BACTERIA FROM THE BOVINE RUMEN [J].
SHOEMAKER, NB ;
WANG, GR ;
SALYERS, AA .
APPLIED AND ENVIRONMENTAL MICROBIOLOGY, 1992, 58 (04) :1313-1320
[75]   Bacteriotherapy with Lactobacillus reuteri in rotavirus gastroenteritis [J].
Shornikova, AV ;
Casas, IA ;
Mykkanen, H ;
Salo, E ;
Vesikari, T .
PEDIATRIC INFECTIOUS DISEASE JOURNAL, 1997, 16 (12) :1103-1107
[76]   A trial in the Karelian Republic of oral rehydration and Lactobacillus GG for treatment of acute diarrhoea [J].
Shornikova, AV ;
Isolauri, E ;
Burkanova, L ;
Lukovnikova, S ;
Vesikari, T .
ACTA PAEDIATRICA, 1997, 86 (05) :460-465
[77]   Lactobacillus reuteri as a therapeutic agent in acute diarrhea in young children [J].
Shornikova, AV ;
Casas, IA ;
Isolauri, E ;
Mykkanen, H ;
Vesikari, T .
JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION, 1997, 24 (04) :399-404
[78]   EFFECT OF LACTOBACILLUS GG YOGURT IN PREVENTION OF ANTIBIOTIC ASSOCIATED DIARRHEA [J].
SIITONEN, S ;
VAPAATALKO, H ;
SALMINEN, S ;
GORDIN, A ;
SAXELIN, M ;
WIKBERG, R ;
KIRKKOLA, AL .
ANNALS OF MEDICINE, 1990, 22 (01) :57-59
[79]   Gene transfer, gentamicin resistance and enterococci [J].
Simjee, S ;
Gill, MJ .
JOURNAL OF HOSPITAL INFECTION, 1997, 36 (04) :249-259
[80]   The effect of consumption of milk fermented by Lactobacillus casei strain Shirota on the intestinal microflora and immune parameters in humans [J].
Spanhaak, S ;
Havenaar, R ;
Schaafsma, G .
EUROPEAN JOURNAL OF CLINICAL NUTRITION, 1998, 52 (12) :899-907